2025 Partners
Find out more about the companies who are partnering with the 9th MASH Drug Development Summit. Get in touch if you would like to partner with us in 2025, and learn more about our bespoke sponsorship opportunities.
Antaros Medical
Expertise Partner
Antaros Medical is pioneering imaging methods, using MRI* and PET**, to both design and
deliver clinical imaging studies. Applied with our extensive experience and expertise in drug
development and disease biology, our tailored solutions have helped our customers to solve
complex problems to empower confident decision-making at every stage of clinical drug
development, from small mechanistic studies to large scale studies. Disease areas: CV, renal & metabolic diseases and oncology.
Perspectum
Expertise Partner
Perspectum delivers leading digital technologies for diagnosis and targeted treatment of patients with metabolic diseases and multi-organ pathologies. Our advanced imaging and digital pathology portfolio and proprietary biomarkers provide accurate, quantifiable insights into the mechanisms and efficacy of therapies. With experience in over 60 commercial clinical trials in MASH and 30 late phase trials, Perspectum is a true partner for design and delivery of smarter, faster and more cost effective MASH clinical trials.
Summit Clinical Research
Hosting Partner
Summit Clinical Research is an Integrated Research Organization which brings together experienced research sites with proven success in the Metabolic Dysfunction-associated Steatohepatitis (MASH) research space. Our mission is to execute comprehensive site recruitment and engagement strategy to achieve the target patient enrollment goal efficiently and cost-effectively within the projected timelines.
We believe patients who participate in clinical trials are partners in their own healthcare. This philosophy is shared by our network of experienced MASH research sites.
Aragen
Exhibition Partner
Aragen Life Sciences is a leading R&D and manufacturing solutions provider for the life sciences industries worldwide. Aragen offers end-to-end integrated or standalone solutions to advance small and large molecule programs from concept to commercialization. Established in 2001, the Company operates through a global network of six sites with a team of 3800+ employees and 450+ PhDs. Its expertise and experience have enabled over 450 customers (including 7 of the top 10 pharma companies globally) in advancing their research programs from early discovery through development and commercialization. Aragen’s innovative mindset, infrastructure, flexible business models, a clear purpose, and proprietary project management platform have enabled it to effectively scale and service large pharma, biotech, agrochemical, and animal health industries globally.
Physiogenex
Event Partner
For 20+ years, we have been evaluating the efficacy of our clients' drugs using gold-standard experiments in our validated preclinical models. Our customers benefit from our experience in drug development and expertise in metabolic diseases, as demonstrated by our numerous co-publications with our industrial partners.
Our expertise - your success.